Join
Live feed
·
PRReleasevia Quantisnow
Foghorn Therapeutics Inc. logo

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

ByQuantisnow·Wall Street's wire, on your screen.
FHTX· Foghorn Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FHTX (Foghorn Therapeutics Inc.) and more on Quantisnow.